A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and tolerability of aripiprazole
in the treatment of children and adolescents with Fragile X Syndrome.